Insider holders · CIK 0001022899
Protagenic Therapeutics, Inc.\new · PTIX
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Gregory EkizianDirector | 645,000 | 100,000 | 745,000 | Jun 22, 2016 · 9:31 am EDT | Form 4 |
| Alexander K. ArrowChief Financial Officer | 358,260 | — | 358,260 | Jun 21, 2016 · 9:56 pm EDT | Form 4 |
| Garo H ArmenSee Remarks | 73,533 | 250,000 | 323,533 | Aug 24, 2026 · 1:20 pm EDT | Form 4 |
| Khalil BarrageDirector | 245,000 | — | 245,000 | Aug 10, 2016 · 7:49 pm EDT | Form 4 |
| Robert Benjamin SteinDirector | 240,000 | — | 240,000 | Jun 21, 2016 · 9:45 pm EDT | Form 4 |
| Joshua SilvermanDirector | 45,000 | — | 45,000 | Jun 21, 2016 · 9:53 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.